Bioequivalence Demonstration for Ω-3 Acid Ethyl Ester Formulations: Rationale for Modification of Current Guidance

Kevin C. Maki, Colleen Johns, William S. Harris, Mark Puder, Steven D. Freedman, Thorsteinn Thorsteinsson, Ahmed Daak, Adrian L. Rabinowicz, Frederick D. Sancilio

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Bioequivalence Demonstration for Ω-3 Acid Ethyl Ester Formulations: Rationale for Modification of Current Guidance'. Together they form a unique fingerprint.

Medicine & Life Sciences